|
Bisphosphonate Treatment of Osteogenesis Imperfecta Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Bisphosphonate Treatment of Osteogenesis Imperfecta conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Bisphosphonate Treatment of Osteogenesis Imperfecta Clinical research trials and Bisphosphonate Treatment of Osteogenesis Imperfecta healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Bisphosphonate Treatment of Osteogenesis Imperfecta. Bisphosphonate Treatment of Osteogenesis Imperfecta Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Bisphosphonate Treatment of Osteogenesis Imperfecta clinical trial. Human subjects often obtain the finest healthcare possible for their Bisphosphonate Treatment of Osteogenesis Imperfecta condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Bisphosphonate Treatment of Osteogenesis Imperfecta Bisphosphonate Treatment of Osteogenesis Imperfecta
Bisphosphonate Treatment of Osteogenesis Imperfecta
For Condition: Osteogenesis Imperfecta
Status: Recruiting
Sponsor(s): Novartis Pharmaceuticals ,
Synopsis: The primary purpose of this trial is to evaluate whether the investigational medication is safe, effective and has the ability to increase spine bone density in osteogenesis imperfecta (OI) patients.
Details: Children with severe osteogenesis imperfecta (OI) suffer recurrent fractures resulting in deformity, bone pain and stunted growth. These patients would have much to gain from the development of a safe and effective treatment for OI.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 3 Months/17 Years
Genders: Both
Protocol Entry Criteria: Inclusion - Male or Female children between 3 months and 17 years old - OI type I, III or IV Exclusion - Deformity or abnormality which would prevent spine bone density from being done - Any surgical bone-lengthening procedure - Any kidney diseases or abnormalities - Low calcium or vitamin D levels in the blood
Total Enrollment: 138
Location and Contact Information:
St. Jude Children's Research Hospital *Recruiting*
Peoria, Illinois, 61637
United States
Recruiting Kathy Kissel 309-624-4945
UCLA - Division of Pediatric Nephrology *Recruiting*
Los Angeles, California, 90024
United States
Recruiting Janet Mooney 310-794-8785
Intermountain Orthopedics *Recruiting*
Boise, Idaho, 83702
United States
Recruiting Jackie Thomason 208-489-4295
Vanderbilt University Medical Center *Recruiting*
Nashville, Tennessee, 37232
United States
Recruiting Karen Adkins 615-322-2742
The Children's Hospital *Recruiting*
Denver, Colorado, 80128
United States
Recruiting Hazel Senz 303-764-8430
Alfred I. DuPont Hospital for Children *Recruiting*
Wilmington, Delaware, 19899
United States
Recruiting Sandra Budd 302-651-6536
Oregon Health Sciences University *Recruiting*
Portland, Oregon, 97201
United States
Recruiting Jennifer Penfield 503-494-7944
Texas Children's Hosptial *Recruiting*
Houston, Texas, 77030
United States
Recruiting Susan Carter 832-822-1630
Children's Hosptial *Recruiting*
Omaha, Nebraska, 68198
United States
Recruiting Kathy Rossiter 402-559-4056
Children's Hospital Medical Center *Recruiting*
Cincinnati, Ohio, 45229
United States
Recruiting Leah Hoechstetter 513-636-4351
Additional Information:
Study ID Numbers: CZOL446H2202;
Study Start Date: June 2003
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063479
Other Osteogenesis Imperfecta Studies:
1. Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
2. Growth Hormone Therapy in Osteogenesis Imperfecta
3. Pamidronate to Treat Osteogenesis Imperfecta in Children
4. Bisphosphonate Treatment of Osteogenesis Imperfecta
Related Studies:
Other Osteogenesis Imperfecta Clinical Trials
Other Oregon Clinical Trials
Other Portland Clinical Trials
Bisphosphonate Treatment of Osteogenesis Imperfecta
|
|
|
|
|
|
|
|